PBPHvsFTXHETF Comparison
Portfolio Building Block World Pharma and Biotech Index ETF
Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) belongs to the DM Large & Mid Cap segment. First Trust Nasdaq Pharmaceuticals ETF (FTXH) is part of the US Health Care segment. PBPH's top 3 sector exposures are Health Care and Consumer Staples. In contrast, FTXH's top sector exposures are Health Care PBPH is less expensive with a Total Expense Ratio (TER) of 0.13%, versus 0.6% for FTXH. PBPH is up 1.62% year-to-date (YTD) with +$830M in YTD flows. FTXH performs better with 8.54% YTD performance, and +$10M in YTD flows. Run a side-by-side ETF comparison of PBPH and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
PBPH vs FTXH performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PBPH FTXH | +3.39%+5.88% | -0.01%+5.50% | +1.62%+8.54% | n/a+38.52% | n/a+39.83% | n/a+46.52% |
| Flows | PBPH FTXH | +$15M-$2M | +$95M+$3M | +$830M+$10M | -+$7M | --$3M | -+$5M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PBPH FTXH | +17.23%+17.81% | n/a+17.04% | n/a+16.28% | n/a+15.91% |
| Max drawdown | PBPH FTXH | -5.84%-4.47% | n/a-7.50% | n/a-19.32% | n/a-19.32% |
| Max drawdown duration | PBPH FTXH | 56d32d | n/a99d | n/a393d | n/a393d |
PBPH | FTXH | |
Last sale 6/17/2026 at 1:30 PM | $25.60 | $35.64 |
| Previous close 06/16/2026 | $25.67 | $35.67 |
| Consolidated volume 06/16/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
PBPH | FTXH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
PBPH | FTXH | |
|---|---|---|
| Last price | $25.60 | $35.64 |
| 1D performance | -0.27% | -0.08% |
| AuM | $802.32 M | $33.90 M |
| E/R | 0.13% | 0.6% |
PBPH | FTXH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Tidal | First Trust |
| Benchmark | BITA Global Pharma and Biotech Select Index | NASDAQ US Smart Pharmaceuticals Index |
| N° of holdings | 49 | 50 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 24, 2025 | September 20, 2016 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
